ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
187 hedge funds and large institutions have $1.49B invested in Array Biopharma Inc in 2017 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 62 increasing their positions, 61 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 61
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
187
Holding in Top 10
4
Calls
$30.6M
Puts
$27.9M
Top Buyers
| 1 | +$115M | |
| 2 | +$55M | |
| 3 | +$41.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$32.4M |
| 5 |
Two Sigma Investments
New York
|
+$20.4M |
Top Sellers
| 1 | -$34.4M | |
| 2 | -$24.3M | |
| 3 | -$19.9M | |
| 4 |
O
OrbiMed
New York
|
-$17M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |